XRP ETF Approval Delayed as SEC Signals Summer Pause

XRP ETF developments continue to stall as the U.S. Securities and Exchange Commission (SEC) delays progress on crypto-related exchange-traded products, according to insight from a top Bloomberg analyst.

James Seyffart, a well-known ETF analyst from Bloomberg, recently shared his expectations that regulatory approvals for upcoming XRP ETPs and other spot crypto ETFs are unlikely to arrive before the end of this summer. While several XRP-based exchange-traded products face upcoming SEC deadlines, Seyffart suggests the commission will likely push decisions into late June or early July — if not later into the fourth quarter.

In a post shared on X (formerly Twitter), Seyffart noted that while deadlines for some XRP offerings are imminent, early green lights from regulators remain improbable. He emphasized that the soonest any approvals might occur would be around mid-summer, and realistically, sometime in Q4.

Seyffart’s stance reflects growing concern among investors and crypto stakeholders who had hoped that the progress made with Bitcoin and Ethereum ETFs could pave the way for quicker regulatory acceptance of other digital asset funds — including those tied to XRP. Despite prior success in launching mainstream crypto investment vehicles, the SEC’s cautious approach persists.

Spot crypto ETFs grant investors the ability to gain market exposure without directly holding the underlying digital assets. This convenience has driven demand, especially among institutional players who prefer traditional financial instruments. Many had anticipated that XRP would be next in line after Bitcoin and Ethereum received ETF approval last year.

Yet, the regulator’s ongoing scrutiny signals a more measured path forward. Analysts suggest that the SEC remains wary of fully embracing broader crypto products until more of its concerns around volatility, market manipulation, and custody solutions are addressed.

Industry leaders have long advocated for integrating cryptocurrency and traditional financial markets. A timely approval for XRP ETFs would act as a milestone in reducing the gulf between decentralized technology and regulated finance. Delays like these, however, hint at persistent regulatory resistance, even as interest in blockchain-based financial solutions continues to grow.

Efforts from major figures in crypto to engage with lawmakers highlight the urgency of achieving regulatory clarity. Recently, Ripple’s CEO journeyed to Washington, D.C., aiming to reinforce discussions on policy changes and secure momentum for digital asset legislation. These actions show the increasing push for collaboration between emerging crypto enterprises and government bodies.

The broader context features attempts by issuers to satisfy compliance requirements while building investor confidence. Many market participants remain optimistic that increased communication will eventually lead to tangible changes. Still, the slower-than-expected timeframe has tempered initial excitement around XRP ETFs becoming widely available this year.

According to current CoinMarketCap data, total cryptocurrency trading volume reached $118.32 billion in the past 24 hours, reflecting a 22.55% decrease from the preceding day. Meanwhile, Bitcoin retains its dominance in the crypto landscape, boasting 63.3% of total market capitalization.

As progress stalls, the future of XRP-based investment products hinges on the SEC’s willingness to adapt to an evolving financial environment. With demand for regulated crypto access growing and pressure mounting from both industry insiders and investors, the spotlight remains fixed on U.S. regulators. Whether decision-makers will accelerate approvals or maintain a wait-and-see approach will determine how rapidly XRP and similar digital assets can mature within the global financial system.

Related: Expert Advice: Sell XRP If You’re Confused

In the meantime, XRP supporters, blockchain proponents, and institutional asset managers will have to exercise continued patience as summer approaches without regulatory resolution.